1/25/2018CFDA Issues the Technical Guidelines for Applications of Phase I New D...

1/25/2018Recent Executive Moves

1/24/2018Upcoming Event: Orthopedics 2018

1/23/2018China Approves Numerous Reform Policies Including New Document for Gen...

1/23/2018Ping An Ventures Led $100M Series A Financing for Cell Therapy Firm Tm...

1/23/2018Clover Biopharma to Make Biosimilars in China with GE Facility

1/23/2018WHO Prequalifies Two Chinese-made Vaccines

1/23/2018Google, Tencent and Sequoia China Join $15M Funding for AI Pharma Star...

1/23/2018Cardiome Announces Expanded Label for Aggrastat in China

1/23/2018GSK Launches Triple-threapy HIV Drug Triumeq in Mainland China with Co...

1/23/2018IQVIA: Chinese Hospital Drug Sales Up 6.2% in Q3/2017

1/23/2018IQVIA: Chinese Retail Pharmacy Sales Up 2. 6% in MAT Q3/2017

1/22/2018Nicholas Hall Reports 8% Growth of OTC Gastrointestinal Market in Chin...

1/22/2018Upcoming Event: 7th International Chronic Obstructive Pulmonary Diseas...

1/22/2018USTR's 2017 Report for China's WTO Compliance Highlight IP Issues in P...

1/19/2018CFDA Solicits Comments on Measures for Drug Evaluation and Approval In...

1/19/2018CFDA Issues Guidance Opinions for Further Strengthening Food and Drug ...

1/19/2018118 Listed Chinese Pharma Cos Report 2017 Performance Guidance

1/19/2018Recent Executive Moves

1/19/2018Xiangxue Pharma Ties Up with GE Unit to Produce Cancer Immunotherapy P...

1/19/2018New Study: 40% of Chinese Adults Suffer from High Blood Pressure

1/19/2018Chinese and American Scientists Find New Approach to Develop Flu Vacci...

1/19/2018Ascletis Seeks Third Round of Funding That Could Exceed US$100M

1/19/2018Made in China: New and Potentially Lifesaving Drugs

1/19/2018Mundipharma to Take Over Marketing of Grunenthal's Pain-Relief Drug in...

1/19/2018CFDA Approves New Indication of Mitsubishi Tanabe's Novastan

1/19/2018Update on US Investigation of China's IP Practices

1/19/2018USDOC Points Out "Shortcomings" in China's Pharma IP Arena

1/19/2018Fosun-Backed Shanghai Henlius Biotech Eyes IPOs on Both Mainland and H...

1/19/2018CITIC Capital Becomes Controlling Shareholder of Harbin Pharma

Page:339/778 Total number of articles:23323: [First][<<] [337] [338] [339] [340] [341] [>>] [End]